
Sign up to save your podcasts
Or


This week, please join author Mathew S. Maurer as he discusses the article "Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260126.13097
By Greg Hundley, MD and Peder Myhre, MD, PhD4.3
3030 ratings
This week, please join author Mathew S. Maurer as he discusses the article "Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20260126.13097

134 Listeners

319 Listeners

503 Listeners

167 Listeners

902 Listeners

299 Listeners

3,376 Listeners

138 Listeners

1,140 Listeners

194 Listeners

90 Listeners

521 Listeners

367 Listeners

440 Listeners

376 Listeners